ABSTRACT
CAPNS1 is essential for stability and function of the ubiquitous calcium-dependent proteases micro- and milli-calpain. Upon inhibition of the endoplasmic reticulum Ca2+ ATPase by 100 nM thapsigargin, both micro-calpain and autophagy are activated in human U2OS osteosarcoma cells in a CAPNS1-dependent manner. As reported for other autophagy triggers, thapsigargin treatment induces Golgi fragmentation and fusion of Atg9/Bif-1-containing vesicles with LC3 bodies in control cells. By contrast, CAPNS1 depletion is coupled with an accumulation of LC3 bodies and Rab5 early endosomes. Moreover, Atg9 and Bif-1 remain in the GM130-positive Golgi stacks and Atg9 fails to interact with the endocytic route marker transferrin receptor and with the core autophagic protein Vps34 in CAPNS1-depleted cells. Ectopic expression of a Bif-1 point mutant resistant to calpain processing is coupled to endogenous p62 and LC3-II accumulation. Altogether, these data indicate that calpain allows dynamic flux of Atg9/Bif-1 vesicles from the Golgi toward the budding autophagosome.
Footnotes
Competing interests
The authors declare no competing or financial interests.
Author contributions
Conceptualization: F.D.; Supervision: F.D., E.-L.E.; Investigation and Formal analysis: E.M., M.P.M., T.A., G.T., M.P.M.; Funding acquisition: F.D., C.S., E.-L.E.; Writing: F.D.
Funding
This work was supported by the European Regional Development Fund and national funds (Cross-Border Cooperation Programme Italy-Slovenia 2007-2013, PROTEO) and by Ministero dell'Istruzione, dell'Universitá e della Ricerca (RBAPMLP2W and CTN01_00177_817708). E.L.E. and T.A. were supported by the Academy of Finland and the Magnus Ehrnrooth Foundation.
Supplementary information
Supplementary information available online at http://bio.biologists.org/lookup/doi/10.1242/bio.022806.supplemental
- Received November 2, 2016.
- Accepted March 13, 2017.
- © 2017. Published by The Company of Biologists Ltd
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.